Your session is about to expire
← Back to Search
Laser Device
PicoSure Pro Device for Tattoo Removal
N/A
Waitlist Available
Led By Sean Doherty
Research Sponsored by Cynosure, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Willing to undergo treatments with the PicoSure and PicoPro devices for pigmentary lesions, acne scars, skin revitalization, or tattoo removal
Willing to undergo treatments with the PicoSure and PicoPro devices for pigmentary lesions, acne scars, skin revitalization, or tattoo removal.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 day follow up
Awards & highlights
Study Summary
This trial is to test the new PicoSure Pro device on additional patients and to collect more data on the device.
Eligible Conditions
- Tattoo Removal
- Wrinkles
- Acne Scars
- Benign Pigmented Lesions
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You are willing to receive treatments using the PicoSure and PicoPro devices to improve skin conditions like dark spots, acne scars, dullness, or to remove tattoos.
Select...
You are willing to receive treatment with specific devices to improve the appearance of pigmentation, acne scars, skin, or to remove tattoos.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 day follow up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 day follow up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Grading of Pre-Treatment vs. Follow Up Images
Trial Design
3Treatment groups
Experimental Treatment
Group I: Group C: Device Only TreatmentExperimental Treatment2 Interventions
Subjects will receive treatments with the PicoSure Pro or PicoSure device on multiple areas of the body such as the face, décolletage, back, legs, arms, and hands.
Group II: Group B: Split-Face Treatment with CosmeceuticalsExperimental Treatment3 Interventions
Subjects will receive a full face treatment with the PicoSure Pro or PicoSure device and will use topical cosmeceuticals on only half of their face.
Group III: Group A: Split-Face Device Only TreatmentExperimental Treatment2 Interventions
Subjects will receive a split face treatment with the PicoSure Pro and/or PicoSure devices using different device settings on each half of the face.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PicoSure Pro Device
2021
N/A
~30
PicoSure Device
2021
N/A
~30
Topical Cosmeceuticals
2021
N/A
~30
Find a Location
Who is running the clinical trial?
Cynosure, Inc.Lead Sponsor
51 Previous Clinical Trials
1,213 Total Patients Enrolled
Jennifer CiviokStudy DirectorDirector of Clinical Research
16 Previous Clinical Trials
469 Total Patients Enrolled
Sean DohertyPrincipal InvestigatorCynosure, Inc.
4 Previous Clinical Trials
226 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Is able to commit to being at all visits, and has the necessary resources to do so.You have a serious illness that affects your whole body, like lupus, or an illness that is in the same area being treated.You are willing to receive treatments using the PicoSure and PicoPro devices to improve skin conditions like dark spots, acne scars, dullness, or to remove tattoos.You currently have an infection or an open wound in the area that will be treated.You are currently taking or have taken gold therapy.You have a condition where you have seizures when exposed to bright lights.Agrees not to have any other procedures on the treatment area during the study.You are very sensitive to light in the near infrared wavelength region.You are taking medication that makes your skin more sensitive to sunlight.You are a man or woman who is 18 years old or older and in good health.You are willing to receive treatment with specific devices to improve the appearance of pigmentation, acne scars, skin, or to remove tattoos.
Research Study Groups:
This trial has the following groups:- Group 1: Group A: Split-Face Device Only Treatment
- Group 2: Group B: Split-Face Treatment with Cosmeceuticals
- Group 3: Group C: Device Only Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this experiment currently accepting participants?
"The most current information on clinicaltrials.gov indicates that this trial is not seeking out any new participants at the moment, despite having been first posted in October 2021 and last modified in September of 2022. However, there are presently 23 other medical studies actively recruiting patients right now."
Answered by AI
Who else is applying?
What state do they live in?
Connecticut
California
How old are they?
18 - 65
65+
What site did they apply to?
Cynosure, Inc.
What portion of applicants met pre-screening criteria?
Met criteria
Share this study with friends
Copy Link
Messenger